Nadeem Sarwar

Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies

My expertise stems from the intersection of genomics, data sciences and digital technologies with collaborative business models to drive innovative therapeutic solutions. I have recently been appointed as the Global Head of Genomic Strategies and Global Head of Digital Therapeutics (DTx) Strategies at Eisai, having previously served as Founder and President of the 100-scientist Eisai Center for Genetics Guided Dementia Discovery (G2D2). I have senior-level experience across academia (University of Cambridge), pharma (Pfizer, Eisai), and Biotech (G2D2); have successfully built and led organizations across the UK, US and Japan; and contributed to delivery of therapeutics into clinical trials for cardiovascular diseases, immunology, oncology, COVID-19 and dementia. I have been invited to provide insights on innovation in therapeutics for The World Dementia Envoy; the UK Department of Health; UK Trades and Investment; the World Economic Forum; the National Academies of Sciences; and the Davos Alzheimer’s Collaborative.

Talks About
#drugdiscovery #genomics

Preferred Locations
#Europe